![Alain Thibault](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alain Thibault
Corporate Officer/Principal bei ANNEXIN PHARMACEUTICALS AB
Aktive Positionen von Alain Thibault
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANNEXIN PHARMACEUTICALS AB | Corporate Officer/Principal | 18.01.2023 | - |
Karriereverlauf von Alain Thibault
Ehemalige bekannte Positionen von Alain Thibault
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
JOHNSON & JOHNSON | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Direktor/Vorstandsmitglied | - | - |
ARGENX SE | Technik-/Wissenschafts-/F&E-Leiter | 19.03.2012 | - |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Finanzdirektor/CFO | - | - | |
Corporate Officer/Principal | - | - | |
University of Virginia | Corporate Officer/Principal | - | - |
Gemin X Pharmaceuticals US, Inc.
![]() Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
REGENERON PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.09.2009 | 14.12.2011 |
Corporate Officer/Principal | 26.02.2007 | 02.09.2009 |
Ausbildung von Alain Thibault
McGill University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Kanada | 2 |
Niederlande | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
REGENERON PHARMACEUTICALS, INC. | Health Technology |
ARGENX SE | Health Technology |
JOHNSON & JOHNSON | Health Technology |
ANNEXIN PHARMACEUTICALS AB | Health Technology |
Private Unternehmen | 3 |
---|---|
Gemin X Pharmaceuticals US, Inc.
![]() Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Börse
- Insiders
- Alain Thibault
- Erfahrung